Recall Z-1582-2018— Radiometer Medical ApS

Class II · Terminated

Class II FDA medical device recall by Radiometer Medical ApS, initiated 2018-02-27, terminated 2019-03-20. It names 3 FDA 510(k) clearances: K151856, K142898, K130144. Product: AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.. Reason: There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up..

Recalling firm
Radiometer Medical ApS
Classification
Class II
Status
Terminated
Initiated
2018-02-27
Terminated
2019-03-20
Firm location
Bronshoj, N/A, Denmark

510(k) clearances named in this recall

3 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.

Reason for recall

There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.

Data sourced from openFDA. This site is unofficial and independent of the FDA.